DENTSPLY SIRONA Inc
NASDAQ:XRAY
Intrinsic Value
Dentsply Sirona, Inc. engages in the design, manufacture, sales and distribution of professional dental products and technologies. [ Read More ]
The intrinsic value of one XRAY stock under the Base Case scenario is 45.29 USD. Compared to the current market price of 30.44 USD, DENTSPLY SIRONA Inc is Undervalued by 33%.
Valuation Backtest
DENTSPLY SIRONA Inc
Run backtest to discover the historical profit from buying and selling XRAY stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
DENTSPLY SIRONA Inc
Current Assets | 2B |
Cash & Short-Term Investments | 334m |
Receivables | 756m |
Other Current Assets | 883m |
Non-Current Assets | 5.4B |
PP&E | 978m |
Intangibles | 4.1B |
Other Non-Current Assets | 276m |
Current Liabilities | 1.4B |
Accounts Payable | 305m |
Accrued Liabilities | 658m |
Other Current Liabilities | 462m |
Non-Current Liabilities | 2.7B |
Long-Term Debt | 1.8B |
Other Non-Current Liabilities | 856m |
Earnings Waterfall
DENTSPLY SIRONA Inc
Revenue
|
4B
USD
|
Cost of Revenue
|
-1.9B
USD
|
Gross Profit
|
2.1B
USD
|
Operating Expenses
|
-1.8B
USD
|
Operating Income
|
296m
USD
|
Other Expenses
|
-428m
USD
|
Net Income
|
-132m
USD
|
Free Cash Flow Analysis
DENTSPLY SIRONA Inc
What is Free Cash Flow?
XRAY Profitability Score
Profitability Due Diligence
DENTSPLY SIRONA Inc's profitability score is 47/100. The higher the profitability score, the more profitable the company is.
Score
DENTSPLY SIRONA Inc's profitability score is 47/100. The higher the profitability score, the more profitable the company is.
XRAY Solvency Score
Solvency Due Diligence
DENTSPLY SIRONA Inc's solvency score is 40/100. The higher the solvency score, the more solvent the company is.
Score
DENTSPLY SIRONA Inc's solvency score is 40/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
XRAY Price Targets Summary
DENTSPLY SIRONA Inc
According to Wall Street analysts, the average 1-year price target for XRAY is 37.78 USD with a low forecast of 30.3 USD and a high forecast of 44.1 USD.
Ownership
XRAY Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
XRAY Price
DENTSPLY SIRONA Inc
Average Annual Return | -5.93% |
Standard Deviation of Annual Returns | 25.31% |
Max Drawdown | -61% |
Market Capitalization | 6.3B USD |
Shares Outstanding | 207 627 008 |
Percentage of Shares Shorted | 5.77% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Dentsply Sirona, Inc. engages in the design, manufacture, sales and distribution of professional dental products and technologies. The company is headquartered in York, Pennsylvania and currently employs 15,000 full-time employees. The firm develops, manufactures and markets solutions, including dental equipment and dental consumable products. The Company’s segments include Technologies & Equipment (T&E) and Consumables. The T&E segment is engaged in designing, manufacturing, sales and distribution of its Dental Technology and Equipment Products and Healthcare Consumable Products. Its products include dental implants, computer-aided design/computer-aided manufacturing systems, orthodontic clear aligner products, imaging systems, treatment centers, instruments, as well as consumable medical device products. The Consumables segment is engaged in designing, manufacturing, sales and distribution of the Company's Dental Consumable Products, which include preventive, restorative, endodontic and dental laboratory products. The company also offers treatment planning and a clear aligner solution delivered directly to a consumer's home.
Contact
IPO
Employees
Officers
The intrinsic value of one XRAY stock under the Base Case scenario is 45.29 USD.
Compared to the current market price of 30.44 USD, DENTSPLY SIRONA Inc is Undervalued by 33%.